BioWorks, a North American company specialised in biological solutions for horticulture, announced the appointment of Chris Rose as Interim General Manager, marking the beginning of a new phase focused on acceleration, disciplined execution, and sales expansion.
Founded in 1993, BioWorks has built a strong legacy under the leadership of Bill Foster, who has guided the company until recently. As part of a planned leadership transition, Chris Rose will now lead the organization into its next stage of growth.
"Today we initiate an important new phase - a phase built on a legacy to honor and an acceleration to execute," said Jonas Hipólito, President of BIOTROP. "BioWorks has strong competitive advantages, deep customer relationships, and an exceptional team. To unlock the next level of value, we sought leadership capable of elevating the business with speed, energy, and creativity. We found those qualities within the company."
Chris Rose, a biologist by training, has been with BioWorks since 2013. Over the past decade, he has held leadership roles across Operations, R&D, and Marketing, combining technical depth with commercial acumen and a deep understanding of growers' needs. He will assume the role of Interim General Manager today, with clearly defined objectives and strong organizational support.
"This is not a reset. It is an acceleration," said Chris Rose. "Our strategy remains clear. Our responsibility now is to execute it effectively - despite market hurdles, competitive pressure, and unexpected challenges. We will start with revenue growth and portfolio expansion, while ensuring our operations scale efficiently as we move forward."
© BioWorks Inc.
BioWorks' next phase will focus on:
Strengthening leadership in horticulture and greenhouse crops; expanding into open-field specialty crops such as grapes, almonds, berries, and other high-value crops; accelerating revenue growth through disciplined commercial execution; maximizing and expanding national coverage across the United States; scaling operations to support portfolio expansion; leveraging BIOTROP's proprietary biological technologies in the U.S. market.
In addition, BioWorks plans to begin exporting its Trichoderma production from its Victor, New York facility to Brazil and Europe, reinforcing the site's strategic role within the group's global manufacturing footprint.
"We are extremely enthusiastic to have Chris step into the General Manager role," said Bill Foster. "This marks the beginning of a new phase of prosperity for BioWorks - a company that has built strong representation in the United States, and now will tap into BIOTROP's technologies and support to generate disciplined growth."
In 2023, BioWorks became part of the BioFirst Group, an expert in biological solutions, and in early 2026, BioWorks transitioned under the management of BIOTROP, headquartered in Brazil, which played a strategic role in supporting BioWorks' growth and innovation roadmap.
Jonas emphasized that this transition reinforces stability and long-term commitment to customers: "Bill built an extraordinary foundation over nearly three decades. We are deeply grateful for his leadership and the culture he established. Our commitment is to preserve that legacy while strengthening it. BioWorks will continue to be an organization that loves its customers, executes with discipline, and grows responsibly."
Bill Foster will remain closely connected to the company during the transition period until the end of May, ensuring continuity and alignment.
2026 portfolio expansion
BioWorks plans to expand its portfolio in 2026 with innovative biological solutions for horticulture, greenhouse crops, and specialty field crops. Production will continue at its Victor, New York, facility, focusing on biological crop protection products for disease and insect control, as well as 100% natural biostimulants.
The company remains firmly committed to delivering sustainable, profitable solutions that enhance plant health and support growers' success.
For more information:
BioWorks
https://bioworksinc.com
